Assessment of the global opportunity for novel biomarkers for atrial fibrillation diagnosis – Evaluation of the Chinese landscape

Optimizing patient access for novel stem cell therapy

Setting up the Global Patient Affairs function

Medical Insights: Process, Governance and Tools for Insights Generation

Early asset assessment informing BD&L due diligence

Early asset assessment informing indication development